Biomarkers Unbound — The Supreme Court's Ruling on Diagnostic-Test Patents

Wednesday, 27 June 2012 15:49

Jason Karlawish argues for the advantages of public ownership and public-private partnerships for the development of biomarkers in his new NEJM piece"Biomarkers Unbound." Penn faculty have been pioneers in the development of predictive biomarkers for Alzheimer's Disease.

Stay Connected

The Latest News

Conference on the Work of CNS's Stephen Morse The work of CNS Associate Director Stephen Morse will be the focus of a neurolaw meeting...
CNS and the School of Arts and Sciences introduce SCAN Penn's new certificate program in Social, Cognitive and Affective Neuroscience (SCAN)...